FORWARD PHARMA A/S: Financial statements 2021
CVR: 28865880
FORWARD PHARMA A/S (CVR 28865880) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK -10,812,930 and a net result of DKK -12,271,137 compared with DKK -42,201,691 the year before. Equity amounted to DKK 461,863,380. The solvency ratio was 82.3%. The company had 2 employees in the financial year.
- Gross Profit
- -10,812,930 kr.
- Profit/Loss
- -12,271,137 kr.
- Equity
- 461,863,380 kr.
- Total Assets
- 561,060,279 kr.
- Employees
- 2
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | -10.8 mio. | -12.3 mio. | 461.9 mio. | 2 |
| 2020 | - | -7.8 mio. | -42.2 mio. | 474.1 mio. | 2 |
| 2019 | - | -6 mio. | -28.5 mio. | 515.9 mio. | 3 |
| 2018 | 0 | -7.6 mio. | -54.3 mio. | 534.6 mio. | 3 |
| 2017 | 1.3 mia. | - | 880.2 mio. | 89.4 mio. | - |
Find more companies like FORWARD PHARMA A/S
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2021
FORWARD PHARMA A/S has published its annual report for 2020. Gross profit came to DKK -7,763,728, and the net result was DKK -42,201,691.
About FORWARD PHARMA A/S
FORWARD PHARMA A/S was a Danish company of the type Aktieselskab based in Hellerup, founded in 2005 and dissolved in 2025. The company was registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company has 4 employees. In 2024, the company reported a gross profit of DKK -9,457,909 and a net result of DKK 75,927,645 compared with DKK -3,832,516 the year before. Equity amounted to DKK 488,330,233.
